Extrovis EU is an API manufacturer based in Switzerland. It holds 8 active US drug master files and one valid CEP across a filed portfolio of 8 molecules. Its filings concentrate with US FDA, EMA and FAMHP (BE).
| Site | FDA FEI |
|---|---|
| Baar, Switzerland | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Dapsone | EDQM, US FDA | 2 |
| Avibactam | US FDA | 1 |
| Calcium Gluconate | US FDA | 1 |
| Dipotassium Phosphate | US FDA | 1 |
| Eltrombopag | US FDA | 1 |
| Monopotassium Phosphate | US FDA | 1 |
| Tolvaptan | US FDA | 1 |
| Trabectedin | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| US FDA | 24 | None |
| EMA | 5 | None |
| FAMHP (BE) | 4 | None |
| AIFA (IT) | 4 | None |
| INFARMED (PT) | 3 | None |
| MPA (SE) | 2 | None |
Choose your molecules and target markets. Extrovis EU comes back tiered against every other supplier able to file there.
Start for free